Arie Mayer Oramed Pharmaceuticals Inc. (ORMP) insider trading activity

ORMP Quotes by TradingView

Arie Mayer is Director of ORAMED PHARMACEUTICALS INC.. Currently has a direct ownership of 96,134 shares of ORMP, which is worth approximately $223,030. The most recent transaction as insider was on Jan 04, 2024, when has been sold 39,325 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 96.1K
0% 3M change
69.22% 12M change
Total Value Held $223,030

Arie Mayer Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 04 2024
BUY
Grant, award, or other acquisition
-
39,325 Added 29.03%
96,134 Common Stock
Apr 17 2023
BUY
Grant, award, or other acquisition
-
30,000 Added 34.56%
56,809 Common Stock
Apr 04 2023
BUY
Open market or private purchase
$8,398 $2.21 p/Share
3,800 Added 12.41%
26,809 Common Stock
Apr 03 2023
BUY
Open market or private purchase
$11,119 $2.22 p/Share
5,009 Added 17.88%
23,009 Common Stock
Jul 28 2022
BUY
Grant, award, or other acquisition
-
12,000 Added 40.0%
18,000 Common Stock
Jan 03 2022
BUY
Grant, award, or other acquisition
-
6,000 Added 40.0%
9,000 Common Stock
Nov 01 2021
SELL
Open market or private sale
$76,800 $25.6 p/Share
3,000 Reduced 100.0%
0 Common Stock
AM

Arie Mayer

Director
Kfar Saba, L3

Track Institutional and Insider Activities on ORMP

Follow ORAMED PHARMACEUTICALS INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ORMP shares.

Notify only if

Insider Trading

Get notified when an Oramed Pharmaceuticals Inc. insider buys or sells ORMP shares.

Notify only if

News

Receive news related to ORAMED PHARMACEUTICALS INC.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on ORMP